Nuevocor Welcomes Dr. Thierry Abribat to its Board of Directors Nuevocor, a Singapore biotech firm, announces the appointment of Dr. Thierry Abribat to its Board, enhancing its leadership in gene therapy for cardiomyopathies.

Nuevocor Welcomes Dr. Thierry Abribat to its Board of Directors #Singapore #Nuevocor #biotech_company #Thierry_Abribat